Adherence to treatment with denosumab, its efficacy and safety in women with postmenopausal osteoporosis in clinical practice
Adherence to treatment with antiosteoporotic drugs is one of the most important factors contributing to their efficacy during longterm therapy. The adherence is assessed by two main lines: firstly, how long a drug is taken and, secondly, whether its dosage regimen is adhered.Subjects and methods. Th...
Saved in:
| Main Authors: | N. V. Toroptsova, O. A. Nikitinskaya, T. A. Korotkova, N. V. Demin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2016-01-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/653 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THREE YEARS' EXPERIENCE WITH THE BIOLOGICAL AGENT DENOSUMAB USED TO TREAT WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: EFFICACY, SAFETY AND TREATMENT ADHERENCE
by: N. V. Toroptsova, et al.
Published: (2017-07-01) -
Effectiveness of Denosumab in Postmenopausal Osteoporosis Treatment: A 1-yr Follow-up Single-center Study
by: Nihal Tezel, et al.
Published: (2021-12-01) -
Comparative evaluation of denosumab efficacy of in patients with rheumatoid arthritis and postmenopausal osteoporosis: results of 1-year study in clinical practice
by: O. V. Dobrovolskaya, et al.
Published: (2019-05-01) -
The Effects of Denosumab Treatment on Pain and Function Beyond Bone Density in Patients With Postmenopausal Osteoporosis: A Prospective Study
by: Miao Zheng, et al.
Published: (2025-06-01) -
Efficacy evaluation of denosumab in the treatment of patients with postmenopausal osteoporosis at high risk of fracture
by: Jing ZHOU, et al.
Published: (2025-02-01)